Latest Articles

  • Managing aneurysmal subarachnoid hemorrhage: It takes a team
    Airton Leonardo de Oliveira Manoel, MD, David Turkel-Parrella, MD, Abhijit Duggal, MD, Amanda Murphy, MD, PhD, Victoria McCredie, MD, FRCPC and Thomas R. Marotta, MD, FRCPC
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 177-192; DOI: https://doi.org/10.3949/ccjm.82a.14021

    There is no silver bullet, but systematic application of small advances maximizes the patient’s chance of recovery.

  • In Reply: Diabetes therapy and cardiac risk (November 2014)
    Robert S. Zimmerman, MD and Kevin M. Pantalone, DO
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 140-141; DOI: https://doi.org/10.3949/ccjm.82c.03002

    A reader comments on diabetes therapy and cardiac risk (November 2013).

  • Left atrial appendage closure: An emerging option in atrial fibrillation when oral anticoagulants are not tolerated
    Left atrial appendage closure: An emerging option in atrial fibrillation when oral anticoagulants are not tolerated
    David C. Peritz, MD and Eugene H. Chung, MD, FACC, FHRS, FAHA
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 167-176; DOI: https://doi.org/10.3949/ccjm.82a.14117

    Can patients undergo a percutaneous procedure to reduce their risk of stroke and avoid lifelong anticoagulation treatment?

  • When the dissociation curve shifts to the left
    Bhuvnesh Aggarwal, MD, Ruhail Kohli, MD, Rendell Ashton, MD and Moises Auron, MD
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 156-160; DOI: https://doi.org/10.3949/ccjm.82a.14044

    The patient’s clinical signs and oxygen saturation monitor indicated hypoxemia, but her blood gases were normal.

  • Is triglyceride therapy worth the effort?
    Michael Miller, MD, FACC, FAHA
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 162-166; DOI: https://doi.org/10.3949/ccjm.82a.13157

    Levels do matter, but no trials of triglyceride-lowering have been done. Weight loss and exercise are encouraged.

  • Does this patient need ultrasonography of the leg to evaluate for deep vein thrombosis?
    C. Jessica Dine, MD, MSHPR and Sara L. Wallach, MD
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 153-155; DOI: https://doi.org/10.3949/ccjm/82a.14071

    If the pretest probability of deep vein thrombosis is low, a normal D-dimer level is enough to rule it out.

  • The health care ‘iron triangle’ and the Patient Protection and Affordable Care Act
    Elmer Philip Lehman, MD, MPP
    Cleveland Clinic Journal of Medicine February 2015, 82 (2) 73-80; DOI: https://doi.org/10.3949/ccjm.82a.14035

    There is no way to increase access, improve quality, and decrease costs all at the same time.

  • Quitting smoking (January 2015)
    Cleveland Clinic Journal of Medicine February 2015, 82 (2) 114;
  • Genetics and hepatitis C: It’s good to be ‘CC’
    Genetics and hepatitis C: It’s good to be ‘CC’
    Jose Mari Parungao, MD, Ibrahim A. Hanouneh, MD, Binu John, MD, Naim Alkhouri, MD and Nizar N. Zein, MD
    Cleveland Clinic Journal of Medicine February 2015, 82 (2) 97-104; DOI: https://doi.org/10.3949/ccjm.82a.14004

    In hepatitis C, people born with the IL28B CC genotype can count themselves luckier than those born with CT or TT.

  • Denosumab: A novel antiresorptive drug for osteoporosis
    Ernest Suresh, MD, FRCP and Bo Abrahamsen, MD, PhD
    Cleveland Clinic Journal of Medicine February 2015, 82 (2) 105-114; DOI: https://doi.org/10.3949/ccjm.82a.13173

    What denosumab is, how it works, how well it works, and practical prescribing tips.

Pages